Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”

Publication date: December 2019Source: Molecular Genetics and Metabolism Reports, Volume 21Author(s): Barry Wolf

Source: Molecular Genetics and Metabolism Reports - September 7, 2019 Category: Genetics & Stem Cells Source Type: research